📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
20
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split
70%
• 50-day avg $0.44 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
55%
• Critical: only 0.1 months cash remaining
📉 Score Deterioration
10%
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$30.93M
Shares Outstanding82.51M
Float57.70M
Cash$20.1K
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest4.7K
Days to Cover1.0
% of Float0.0%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
No recent SEC insights
📰 Recent News
No recent news
🔬 More Research for EMGDF
📊 EMGDF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EMGDF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.